Major Honey Bee Diseases and Possibilities to Control Them with Essential Oils Authors: Yordan V. Hristov, Koycho Koev, Tsvetan Tsvetanov, Ralitsa Balkanska Published: 2026 ABSTRACT Simple SummaryHoneybee diseases can weaken colonies, reduce honeybee survival, lower productivity, and threaten pollination, which is important for agriculture and biodiversity. This review summarizes current knowledge on the possible use of essential oils as natural supportive tools for managing important honeybee diseases. The reviewed studies show that some essential oils and their plant compounds can limit the growth of disease-causing organisms or affect parasites under laboratory conditions. The strongest practical evidence is available for thymol-based products against the mite Varroa destructor, while evidence for bacterial, fungal, and intestinal diseases is less consistent. The effectiveness of essential oils in real colonies depends on their composition, dose, method of application, temperature, colony condition, and safety for bees and brood. Essential oils should therefore be considered promising complementary tools rather than complete replacements for established disease-control methods. These findings may support more sustainable beekeeping and help protect honeybee colonies that are essential for food production and natural ecosystems. 1. Introduction Honeybees (Apis mellifera) are among the most economically and ecologically important pollinators, providing essential pollination services for both agricultural crops and wild plant species [1]. Recent global evidence further shows that insufficient pollinator visitation limits yield in a substantial proportion of crop systems, reinforcing the current agricultural relevance of protecting pollination services [2]. In recent decades, beekeepers in Europe, North America, and other regions have reported increasing colony weakening and elevated colony losses [3,4]. These losses are widely recognized as multifactorial, arising from complex interactions among pathogens, parasites, pesticide exposure, nutritional stress, climate-related factors, and beekeeping practices, rather than from a single causative agent [5]. Among these drivers, infectious and parasitic diseases play a central role in colony decline and reduced productivity. Honeybee colonies are affected by a broad spectrum of pathogens and parasites, including bacteria, fungi, viruses, microsporidia, and mites [6]. Among bacterial diseases, American foulbrood (AFB), caused by Paenibacillus larvae (P. larvae), is one of the most destructive brood diseases due to its high lethality and the long-term persistence of spores in hive materials [7,8,9]. A recent review continues to describe AFB as a persistent and internationally relevant brood disease because spore durability, bacterial virulence, diagnosis, and control measures remain central to outbreak management [10]. European foulbrood (EFB), primarily associated with Melissococcus plutonius (M. plutonius), is another economically significant brood disease, mainly affecting uncapped larvae [11,12]. Updated EFB research standards also emphasize that M. plutonius pathogenesis remains incompletely resolved and that modern molecular and diagnostic methods are needed for comparable disease studies [13]. In addition, the ectoparasitic mite Varroa destructor (V. destructor) represents one of the most serious global threats to apiculture, owing to both its direct parasitic effects and its role in the transmission and amplification of honeybee viruses, particularly deformed wing virus (DWV) [14,15]. Recent scoping evidence reinforces this assessment by synthesizing V. destructor effects on reproduction, immunity, longevity, virus transmission, and the limitations of available control methods [16]. The role of V. destructor in viral transmission and amplification is further supported by DWV-specific and global honeybee viral landscape studies [17,18]. Other viral pathogens, including acute bee paralysis virus (ABPV) and chronic bee paralysis virus (CBPV), are also relevant because overt infections can be associated with paralysis, adult mortality, and colony-level weakening [19,20,21]. Microsporidian infections caused by Nosema apis (N. apis) and Nosema ceranae (N. ceranae) further contribute to colony health impairment by reducing adult bee lifespan, weakening physiological condition, and lowering colony productivity [22,23]. Chalkbrood, caused by the fungus Ascosphaera apis (A. apis), is generally less severe than AFB or uncontrolled varroosis but can still weaken colonies and reduce productivity under favorable environmental and colony conditions [24]. These diseases pose a significant challenge to sustainable beekeeping and necessitate effective, safe, and practical control strategies. Current disease-control options remain limited. The use of antibiotics against bacterial brood diseases is restricted in many countries and may suppress clinical symptoms without eliminating persistent infectious stages [25]. Antimicrobial resistance and residues in bee products raise important regulatory and food safety concerns [26]. Synthetic acaricides are widely applied against V. destructor, but their long-term effectiveness is increasingly compromised by resistance development and the accumulation of chemical residues in hive matrices [27,28]. Fumagillin has been used for the control of nosemosis in some regions; however, its application is restricted in Europe due to toxicological and residue-related concerns [29]. For chalkbrood, no consistently effective and widely accepted chemical treatment has been established [30]. These limitations have stimulated growing interest in alternative and complementary approaches for the management of honeybee diseases. Among these, essential oils have attracted particular attention because they contain biologically active compounds with antibacterial, antifungal, acaricidal, antioxidant, and host-supportive properties. The available evidence remains uneven: while numerous studies demonstrate strong in vitro activity, relatively few provide robust data on field efficacy, bee safety, standardized formulations, and practical application under colony conditions. This discrepancy between laboratory results and field applicability represents a major challenge in evaluating essential oils as disease-control agents. Therefore, the present review aims to summarize the major honeybee diseases and to critically assess the potential, mechanisms, limitations, and future perspectives of essential oils in their control. Within this scope, the review synthesizes evidence on essential-oil chemistry, biological mechanisms, disease-specific efficacy, safety, formulation, and translational limitations relevant to honeybee disease control. Review Framework and Literature Selection This article was prepared as a narrative review using a structured literature-selection framework. The search covered peer-reviewed and otherwise verifiable scientific literature published up to June 2026. PubMed, Scopus, and Web of Science were used as the primary bibliographic databases, and the reference lists of eligible primary studies and recent reviews were screened to identify additional relevant publications. The database search identified 291 records before selection (PubMed, n = 111; Scopus, n = 80; Web of Science, n = 100). The evidence was synthesized qualitatively by disease category, experimental model, biological outcome, safety endpoint, and relevance to practical apicultural application. Searches were conducted in title, abstract, and keyword fields when supported by the respective database platform. The principal search string combined host, intervention, disease, and outcome terms as follows: (Apis mellifera OR honeybee OR “honey bee”) AND (“essential oil” OR “essential oils” OR “plant extract” OR “plant-derived compound” OR “natural product” OR phytochemical OR thymol OR carvacrol OR eugenol OR linalool OR menthol OR eucalyptol OR nanoemulsion OR microencapsulation OR “controlled release”) AND (“American foulbrood” OR “European foulbrood” OR Paenibacillus larvae OR Melissococcus plutonius OR Varroa destructor OR varroosis OR Nosema apis OR Nosema ceranae OR nosemosis OR Ascosphaera apis OR chalkbrood OR “deformed wing virus” OR “acute bee paralysis virus” OR “chronic bee paralysis virus”) AND (“antibacterial activity” OR “antifungal activity” OR “acaricidal activity” OR “antiviral relevance” OR “antioxidant activity” OR toxicity OR “brood safety” OR “queen safety” OR “gut microbiota” OR “field efficacy”). Disease-specific searches used the same host and intervention blocks combined with targeted pathogen and outcome combinations for American foulbrood and European foulbrood, varroosis, nosemosis, chalkbrood, honeybee viruses, essential-oil formulations, microbiota effects, and colony-level safety. Search terms were adapted to the syntax of each database without changing the underlying concept blocks. Sources were eligible when they addressed at least one major honeybee disease caused by bacteria, fungi, microsporidia, mites, or viruses; the biological activity of essential oils, plant extracts, formulations, or isolated plant-derived compounds against honeybee pathogens or parasites; mechanisms of antibacterial, antifungal, acaricidal, antiviral, antioxidant, or host-supporting action; adult-bee, brood, queen, colony, or microbiota safety; or semi-field and field application in apiculture. Peer-reviewed primary studies were prioritized for efficacy and safety claims, while review articles, methodological papers, and essential-oil chemistry studies were used for background, interpretation, and citation tracking. Sources were excluded when bibliographic metadata could not be verified, when the report was not directly relevant to honeybee diseases or essential-oil-based disease control, when the biological outcome was not extractable, when the same data were available in a more complete publication, or when claims could not be traced to peer-reviewed or otherwise verifiable scientific evidence. Studies based only on non-honeybee pathogens, non-apicultural systems, or non-essential-oil interventions were used only when they clarified general mechanisms and were not treated as direct evidence of honeybee-disease control. Studies presented in Tables were selected when they provided an identifiable oil, compound, extract, or formulation; a defined target disease, pathogen, or parasite; a dose, concentration, or exposure unit; an experimental model and control or comparator information where available; and a measurable efficacy, toxicity, safety, or colony-level endpoint. Priority was given to studies that supported cross-disease comparison, dose–response interpretation, chemical or formulation relevance, field translation, or critical evaluation of evidence strength. Studies with incomplete control information, heterogeneous units, or limited colony-level endpoints were retained only when their limitations could be explicitly interpreted. The selection pathway consisted of database and citation-chain identification, duplicate and relevance screening, title and abstract assessment against the review scope, full-text or metadata verification where available, and qualitative extraction of the target disease, oil or compound, model, dose, outcome, safety endpoint, and main limitation. Of the 291 records initially identified, 177 were not retained after duplicate checking, relevance screening, bibliographic verification, and citation-chain evaluation. The remaining 114 sources were retained for qualitative synthesis. Evidence strength was interpreted according to experimental scale (in vitro, cage, semi-field, or field), reproducibility, clarity of controls or comparators, dose reporting, bee-safety endpoints, and translational relevance. 2. Essential Oils: Definition and Chemical Composition Essential oils are volatile, lipophilic mixtures of plant secondary metabolites, typically obtained by steam or hydrodistillation from aromatic plants or specific plant parts. According to the Association Française de Normalisation, an essential oil is defined as a product obtained from plant material by distillation with water or steam, by mechanical processing of the epicarp of Citrus fruits, or by dry distillation [31]. These oils are generally composed of low-molecular-weight compounds that are poorly soluble in water but readily soluble in organic solvents [32,33,34]. The biological activity of essential oils is closely linked to their chemical complexity. Most essential oils contain dozens of individual constituents, although two or three major compounds often account for a substantial proportion of the total composition [35]. Importantly, minor constituents—even at low concentrations—may significantly influence overall biological activity through additive, synergistic, or antagonistic interactions with dominant compounds. This aspect is particularly relevant in the context of honeybee disease control, where antimicrobial, antifungal, acaricidal, or antioxidant effects may depend on the full chemical profile rather than on a single active component. The chemical composition of essential oils is highly variable and influenced by multiple factors, including plant species, chemotype, geographical origin, climatic conditions, soil characteristics, phenological stage, harvesting time, plant part used, and extraction method [36]. Such variability directly affects the quality, efficacy, and safety of essential oils. Consequently, studies evaluating their activity against honeybee pathogens or parasites should ideally include detailed chemical characterization, as oils derived from the same botanical species may differ substantially in composition and biological activity. The major constituents of essential oils predominantly belong to the chemical classes of terpenoids and phenylpropanoids. Terpenoids constitute the largest group and include monoterpenes and sesquiterpenes, along with their oxygenated derivatives such as alcohols, aldehydes, ketones, phenols, ethers, esters, and epoxides [33,37]. Examples of biologically active terpenoid compounds relevant to honeybee health include thymol, carvacrol, linalool, menthol, geraniol, eucalyptol, and citral. Phenylpropanoids, although generally present in lower concentrations, include important bioactive compounds such as eugenol and cinnamaldehyde [38]. Due to their chemical diversity, essential oils can exert multiple biological effects through different mechanisms of action. Their constituents may disrupt microbial cell membranes, interfere with fungal cell wall integrity, affect mite nervous systems, modulate oxidative processes, and, in some cases, influence honeybee physiological responses. This multi-component and multi-target mode of action underlies the growing interest in essential oils as alternative or complementary tools for controlling major honeybee diseases. However, it also presents challenges related to standardization, reproducibility, dosage optimization, and safety evaluation. Recent biopesticide literature further shows that essential-oil development is increasingly focused on formulation technology, non-target selectivity, environmental fate, and commercialization constraints, rather than on chemical composition or in vitro bioactivity alone [39]. For readability, the principal chemical groups of essential-oil constituents and their relevance to honeybee-disease research are summarized in Table 1 [33,35,36,37,38]. 3. Biological Roles and Mechanisms of Action of Essential Oils 3.1. Antibacterial Activity The antibacterial activity of essential oils is primarily associated with their hydrophobic and lipophilic properties. Many essential oil constituents can interact with bacterial cell membranes, disrupt lipid organization, increase membrane permeability, and induce leakage of ions and intracellular components, ultimately impairing bacterial viability [40]. Gram-positive bacteria are generally more susceptible than Gram-negative bacteria due to the absence of an outer membrane barrier; however, susceptibility varies depending on bacterial species, oil composition, and experimental conditions [40]. In addition to membrane disruption, essential oils may interfere with bacterial metabolism and virulence-related processes. For instance, carvacrol and p-cymene have been associated with alterations in protein synthesis in Escherichia coli [40], while certain essential oils have been reported to reduce protease activity in P. larvae, the causative agent of AFB [41]. Given their complex composition, the antibacterial effects of essential oils often result from additive or synergistic interactions among multiple constituents. This multi-target mode of action may reduce the likelihood of rapid resistance development; however, it should not be interpreted as evidence that resistance cannot occur. For spore-forming pathogens such as P. larvae, these antibacterial mechanisms primarily concern metabolically active vegetative cells; dormant endospores are structurally protected and metabolically quiescent. Therefore, growth inhibition or protease inhibition should be distinguished from sporicidal activity, inhibition of spore germination, or reduction in spore contamination in hive matrices; the reviewed essential-oil data do not demonstrate reliable inactivation of dormant P. larvae endospores [7,8,9,10,41]. 3.2. Antiviral Relevance Essential oils and their constituents have been reported to affect viruses in several non-apicultural experimental systems; however, these data do not establish direct antiviral efficacy against honeybee viruses [42]. Accordingly, the virus-related relevance of essential oils in apiculture should be interpreted cautiously and primarily in relation to bee-specific evidence and indirect effects on mite-associated viral pressure. Honeybee colonies are affected by several clinically relevant ribonucleic acid (RNA) viruses. Deformed wing virus (DWV) is central because its overt clinical expression and colony-level impact are strongly linked to V. destructor-mediated transmission and viral amplification [17,18]. The acute bee paralysis virus–Kashmir bee virus–Israeli acute paralysis virus (ABPV–KBV–IAPV) complex may persist covertly but can become highly virulent, especially in mite-infested colonies [19], whereas chronic bee paralysis virus (CBPV) primarily affects adult bees and has increased in some managed honeybee populations [20,21]. Bee-specific studies do not support treating essential oils as direct antiviral therapies. Short-term dietary exposure to phytochemicals, including thymol, has been associated with reduced DWV levels, but higher doses of thymol and clove oil increased mortality [43]. Thyme-oil-supplemented sucrose syrup reduced DWV abundance together with immune-gene changes, suggesting immunomodulation rather than a proven virucidal effect [44]. Conversely, encapsulated thymol and carvacrol did not significantly improve survivorship in an IAPV cage-bioassay [45], and the effects of garlic oil and oregano oil against DWV were mostly non-significant [46]. Thus, no essential-oil treatment is field-validated as a direct antiviral therapy against DWV, ABPV, CBPV, or other honeybee viruses. The most defensible virus-related role is indirect: effective control of V. destructor may reduce vector-mediated viral amplification and mite-associated viral pressure, but this should be evaluated by simultaneously measuring mite infestation, viral loads, colony outcomes, dose-dependent toxicity, and bee safety. 3.3. Antifungal Activity The antifungal activity of essential oils is commonly linked to their effects on fungal cell membranes, cell walls, and mitochondrial function. Essential oil constituents may disrupt membrane integrity by interacting with ergosterol or by interfering with its biosynthesis [47]. They may impair mitochondrial activity, reduce adenosine triphosphatase (ATPase) function, increase the production of reactive oxygen species, and inhibit key enzymes involved in cell wall synthesis, including β-glucan synthase, sterol reductases, and chitin synthase [47]. These mechanisms are particularly relevant to chalkbrood, caused by A. apis, as inhibition of fungal growth or spore development may reduce pathogen pressure in brood. These mechanistic observations support antifungal potential, but they do not by themselves establish colony-level chalkbrood control. 3.4. Acaricidal Activity Acaricidal activity is of primary importance in the control of V. destructor. Essential oils may affect mites through contact, fumigation, or ingestion-related exposure. At the organismal level, toxicity may involve impaired respiration, disruption of cuticular integrity, behavioral alterations, reduced growth, decreased fecundity, and mortality [48]. At the biochemical level, three mechanisms are particularly relevant: inhibition of acetylcholinesterase, interference with octopaminergic signaling, and modulation of γ-aminobutyric acid (GABA)-gated chloride channels [49,50,51]. Effective varroosis control requires selectivity—compounds must be significantly more toxic to mites than to adult bees, larvae, and queens. Evaluation of essential oils for Varroa control should include not only mite mortality but also bee safety, brood effects, formulation stability, and performance under field conditions. 3.5. Antioxidant Activity Antioxidant activity represents another important biological property of many essential oils. From a chemical perspective, lipid peroxidation is a radical chain reaction involving reactive intermediates such as alkylperoxyl radicals. Antioxidants can inhibit these processes by scavenging free radicals, interrupting chain propagation, or forming less reactive intermediates [52]. Several essential oil constituents—particularly phenolic compounds such as thymol, carvacrol, and eugenol—are capable of donating hydrogen atoms to peroxyl radicals, thereby forming relatively stable phenoxyl radicals and limiting oxidative chain reactions. Other compounds may act as termination enhancers or participate in redox reactions that generate less reactive species, as described for γ-terpinene [53]. These antioxidant effects may contribute not only to pathogen control but also to the mitigation of oxidative stress in bees. 3.6. Stimulating and Health-Promoting Effects on Bee Colonies In addition to their direct activity against pathogens and parasites, certain essential oils and plant-derived products have been reported to exert beneficial effects on honeybee health and colony performance. For example, lemongrass and spearmint oils have been associated with increased worker lifespan under cage conditions. Similarly, plant extracts or essential oils derived from garlic, Echinacea, Ganoderma, sage, oregano, thyme, basil, and mint have been reported to influence queen oviposition, brood production, intestinal microbial load, and honey yield in selected studies [54,55]. Recent microbiota-oriented evidence moves this issue beyond general intestinal-load measurements: Ewert et al. [55] evaluated ingested essential oils and propolis extracts in relation to life span, nutrient assimilation, xenobiotic-detoxification markers, and gut bacterial abundance, indicating that supportive products may have microbiota- and physiology-dependent effects rather than uniformly beneficial outcomes. Recent survey-based evidence from Bulgaria adds a field-level context to this interpretation. Koev et al. [56] analyzed climatic conditions during 2021–2024 and a 2024 survey of 70 beekeepers managing 8935 colonies; reported winter mortality in the 2023/2024 season was 2.22% within the surveyed sample and occurred in apiaries where parasite control and herbal complementary feeding schemes were commonly used, but the observational design, self-reported data, and absence of unsupplemented controls preclude causal inference. Although these findings are promising, they should be interpreted with caution. Observed effects may depend on colony condition, season, dosage, route of administration, and formulation. General colony stimulation does not necessarily equate to effective disease control, and further controlled field studies are required to clarify these relationships. Table 2 consolidates these biological activities by target, mechanism, relevance, and representative compounds. 4. Efficacy of Essential Oils Against Major Honeybee Diseases The strength of evidence differs substantially across experimental models. In vitro assays are useful for initial screening of antimicrobial, antifungal, acaricidal, or antiviral activity under controlled exposure conditions, but they do not reproduce colony architecture, brood thermoregulation, social immunity, food distribution, volatilization dynamics, or pathogen transmission within the hive. Cage assays provide information on individual-level survival, toxicity, infection intensity, and dose response, yet they exclude queen status, brood effects, colony demography, foraging behavior, and environmental variation. Semi-field studies offer an intermediate level of biological relevance by testing delivery under apiary conditions, whereas field trials provide the strongest practical evidence because they assess colony-level efficacy, safety, treatment delivery, seasonality, and recurrence. Therefore, laboratory findings should be interpreted as hypothesis-generating unless they are supported by reproducible semi-field or field data with appropriate controls, standardized outcome measures, and concurrent assessment of bee and brood safety. A balanced interpretation also requires explicit consideration of negative and inconclusive results, because selective emphasis on inhibitory activity or mite mortality may overestimate practical value when unsuccessful field applications, dose-limiting toxicity, weak replication, or formulation failure are not given equal weight. 4.1. American Foulbrood (AFB) AFB, caused by P. larvae, is among the most extensively studied honeybee diseases in the context of essential oils. The available evidence is strongest at the in vitro level, where experimental conditions—such as oil composition, concentration, and exposure time—are well defined. Calderone et al. [57] reported that cinnamon oil at 10 µg/mL (reported as 10 ppm) inhibited P. larvae growth for 72 h, whereas camphor and citronellal oils were active at 100 µg/mL (reported as 100 ppm); bay, clove, and oregano oils, as well as thymol, required 1000 µg/mL (reported as 1000 ppm), and α-terpinene required 10,000 µg/mL (reported as 10,000 ppm) under comparable conditions. Alippi et al. [58] screened eight essential oils and identified lemongrass and thyme oils as the most effective inhibitors of P. larvae growth. Subsequent studies have confirmed antibacterial activity for cinnamon oil, cinnamaldehyde, eugenol, thymol, tea tree oil, oregano oil, clove oil, and grapefruit oil [41,59,60,61,62]. These findings indicate that P. larvae is susceptible to several phenolic and phenylpropanoid constituents, particularly thymol, carvacrol, eugenol, and cinnamaldehyde. Fuselli [59] and co-workers reported a synergistic inhibitory effect for a mixture composed of 62.5% thyme oil, 12.5% cinnamon oil, and 25% thymol, suggesting that combinations of oils or purified constituents may be more effective than single compounds. This observation highlights a key concept: the biological activity of essential oils typically reflects interactions among multiple constituents rather than the effect of a single dominant compound. Consequently, these in vitro assays should be interpreted primarily as evidence of inhibition of vegetative-cell growth or activity of P. larvae under culture conditions; they do not demonstrate endospore inactivation unless spore viability, viable-spore counts, or germination after exposure is directly measured [7,8,9,10,57,58]. Thus, the reviewed in vitro evidence supports antibacterial activity against vegetative P. larvae cells, but not sporicidal activity against dormant endospores. Despite robust in vitro evidence, field and semi-field data for AFB remain limited and inconsistent. Floris et al. [63] administered Cinnamomum sp. essential oil at 400 mg/kg in semi-solid feed to colonies affected by AFB and reported a reduction in clinical signs, while also emphasizing challenges related to treatment timing and delivery. Gende et al. [60] applied Cinnamomum zeylanicum essential oil at two doses of 1000 µg/mL per hive at 7-day intervals and observed a significant reduction in infected larvae compared with untreated controls. Albo et al. [64] reported that several essential oils (savory, thyme, lemongrass, oregano) and their mixtures failed to prevent or eliminate clinical AFB under field conditions, and Puvača [65] reported insufficient efficacy of lavender oil. These contrasting colony-level outcomes indicate that the predictive value of antibacterial screening is limited when treatment delivery, brood exposure, infection pressure, and persistence of P. larvae endospores are not evaluated under realistic hive conditions. The discrepancy is biologically important because transient suppression of vegetative cells does not necessarily reduce the infectious spore reservoir in brood remains, wax, honey, or equipment [8,9,10,63,64,65]. Essential oils cannot currently be considered established treatments for AFB. Rather, they should be viewed as promising candidates for complementary control strategies, requiring further validation at the colony level, particularly with respect to spore persistence and long-term disease dynamics. The current evidence is therefore best classified as strong for in vitro inhibition of vegetative cells, but not as evidence of reliable sporicidal activity against dormant endospores, and weak to moderate for reproducible colony-level disease control. The negative field results reported for savory, thyme, lemongrass, oregano, mixed-oil applications, and lavender oil are therefore not peripheral observations; they define the present boundary between antibacterial potential and dependable disease management under apiary conditions [64,65]. Future AFB studies should therefore report vegetative-cell minimum inhibitory concentration (MIC), inhibition-zone, or virulence-factor endpoints separately from endospore-germination, endospore-viability, contaminated-matrix, and recurrence endpoints. Recent laboratory evidence has expanded the foulbrood evidence base by directly testing a broad panel of essential oils against both P. larvae and M. plutonius while also assessing worker-bee tolerance to vapor exposure. Marianelli and Narciso identified oregano, juniper, sage, thyme, cinnamon, cumin, clove, and black pepper oils among the most active against foulbrood bacteria; however, bee tolerance differed among oils and toxicity increased with longer exposure time [66]. This study is valuable because it links pathogen inhibition with adult-bee safety screening, but it remains laboratory-based; larval bioassays and field trials are still required before clinical disease-control claims can be made. 4.2. European Foulbrood (EFB) Compared with AFB, substantially fewer studies have evaluated essential oils against EFB, primarily associated with M. plutonius. Calderone et al. [57] demonstrated that cinnamon oil and thymol at 10 µg/mL (reported as 10 ppm) completely inhibited Paenibacillus alvei (P. alvei), a frequent secondary invader in EFB, over 72 h. Studies using Polygonum bistorta essential oil have reported activity against both P. larvae and M. plutonius, although the inhibitory effect against M. plutonius was weaker. Santos et al. [61] reported strong inhibitory activity of tea tree oil, including nanoparticle formulations, against both pathogens, while Hassona [67] suggested potential field relevance of clove oil. Despite these encouraging findings, the evidence base for EFB remains limited. Importantly, EFB pathogenesis is multifactorial and influenced by larval nutrition, colony strength, environmental stressors, and secondary bacterial invaders. Consequently, antibacterial activity against isolated pathogens cannot be directly extrapolated to reliable disease control at the colony level. The limited number of studies directly targeting M. plutonius, together with reliance on surrogate or secondary bacterial targets in some experiments, increases uncertainty and limits reproducibility across EFB models. The recent inclusion of M. plutonius in direct essential-oil screening strengthens the relevance of EFB-specific evaluation, but it also confirms that antibacterial activity must be interpreted together with exposure-related bee toxicity and colony-level validation [66]. From a practical standpoint, the EFB evidence remains particularly vulnerable to overinterpretation because inhibition of P. alvei or isolated M. plutonius does not demonstrate reversal of brood disease, prevention of recurrence, or reliable performance in nutritionally stressed colonies. 4.3. Varroosis Varroosis, caused by V. destructor, represents the most practically relevant area for the application of essential oils in apiculture. Numerous laboratory studies have demonstrated acaricidal activity of essential oils and their constituents; however, results are often difficult to compare due to methodological heterogeneity, including differences in mite collection, exposure routes, dose expression, environmental conditions, and mortality assessment. Moreover, bee and brood toxicity are not consistently evaluated, despite being critical for practical application. Evidence quality is strongest when studies report mite mortality together with bee mortality, brood effects, exposure route, temperature, release kinetics, and an established acaricide or untreated control. Negative or suboptimal outcomes are especially important in this section because a treatment that reduces mite numbers only partially, or only under narrow temperature and delivery conditions, may still leave colonies exposed to damaging mite and virus pressure. A wide range of essential oils have demonstrated acaricidal activity against V. destructor, including oils from Tagetes minuta, Schinus molle, Heterotheca latifolia, Heterothalamus alienus, Citrus spp., Cymbopogon citratus, eucalyptus, clove, anise, oregano, mint, and thyme [68,69,70,71,72,73]. Quantitative studies provide more meaningful comparisons when endpoint terminology and dose expression are reported consistently. For example, Eguaras et al. [68] reported a median lethal dose (LD50; DL50 in the original article) of 4.37 mg/cage for Tagetes minuta oil after 24 h, while Ruffinengo et al. [69] reported an LD50 of 2.65 µL/cage for Schinus molle oil, with a selectivity ratio above 16, indicating higher toxicity to mites than to bees. Sabahi et al. [71] reported median lethal concentration (LC50) values of 304.9 µg/mL for anethole and 474.13 µg/mL for Cymbopogon citratus oil, with relatively low toxicity to bees and larvae. Citrus oils also showed substantial mite mortality in vitro, with bergamot, grapefruit, and lemon oils achieving approximately 80%, 70%, and 69% mortality, respectively [72]. These quantitative data highlight both the potential and a major limitation of the field: differences in endpoint type, dose expression, exposure route, and experimental system limit direct comparison and ranking of candidate oils. More recent chemically characterized studies reinforce the need to evaluate acaricidal activity together with bee safety. Erdoğan reported strong fumigant and repellent effects of Origanum acutidens and Satureja hortensis oils against V. destructor, with larval mortality remaining below 5% in the tested treatments [74]. Manzo et al. [75] showed that Patagonian wild-plant oils differed markedly in toxicity to mites, adult bees, and larvae, indicating that selectivity is oil-specific and cannot be assumed from botanical origin alone. Field efficacy depends strongly on formulation and delivery systems. Laboratory activity does not necessarily translate into effective hive-level control, as factors such as evaporation rate, temperature, colony strength, brood presence, and treatment duration determine actual exposure. Thymol remains the most substantiated essential-oil-based compound for varroosis control. Lindberg et al. [76] reported high mite mortality with thymol and clove oil under laboratory conditions, while Gashout and Guzmán-Novoa [77] reported LC50 values of 56.1 µg/vial for thymol and origanum oil in a glass-vial residual bioassay. Begna et al. [78] reported LC50 values of 71 µg/mL for thymol and 42 µg/mL for a thymol–carvacrol mixture, with the mixture showing higher toxicity to mites than fluvalinate in that experimental model. Consequently, thymol-based products occupy a different evidentiary category from many other essential oils: their practical relevance is supported by formulation-dependent field evidence, whereas most non-thymol oils remain supported mainly by laboratory or small-scale assays. Recent studies from 2024 to 2026 make this formulation-dependent evidence more explicit. Semi-field and field testing of Citrus bergamia and Citrus limon oils showed no bee toxicity in semi-field cages, but field mite mortality at the highest concentrations reached only 40.3% and 50.7%, respectively, supporting the need for gradual and controlled release under hive conditions [79]. In contrast, colony-level testing of peppermint, thyme, and eucalyptus nanoemulsions reported concentration-dependent reductions in Varroa infestation, with the highest efficacy for thyme nanoemulsion at 200 µg/mL (reported as 200 ppm), although the authors emphasized that brood safety, residues, and broader bee-health endpoints still require evaluation [80]. A thymol nanoemulsion colony trial similarly suggested potential dose reduction, but the highest numerical mite fall did not translate into statistically clear superiority among groups, showing that nanoformulation alone does not guarantee robust colony-level efficacy [81]. Integrated pest-management studies also remain important: a field trial combining registered amitraz and thymol products achieved rapid Varroa control comparable to amitraz emulsifiable concentrate at 21 days, but lower bee populations in the combination group indicated that timing, dose, and colony-strength effects require optimization [82]. These examples show that recent studies do not uniformly support immediate practical adoption: moderate field mite mortality, statistically unclear treatment separation, and reduced bee populations in some combination-treatment groups all argue for cautious interpretation rather than simple classification as successful alternatives [79,81,82]. To provide a more detailed comparison of acaricidal efficacy, selectivity, and formulation-dependent outcomes, representative experimental data on essential oils tested against V. destructor are summarized in Table 3. Delivery method appears to be a critical determinant of efficacy. Sabahi et al. [87] reported 57.8% efficacy for oregano oil delivered via impregnated absorbent pads, whereas efficacy increased to 97.4% when continuous-release vaporizers were used. These findings clearly demonstrate that formulation and delivery systems are not merely technical details but key determinants of biological and practical outcomes. The lower efficacy of impregnated pads compared with continuous-release vaporizers illustrates how a biologically active oil can fail operationally when release kinetics do not sustain an effective hive concentration [87]. 4.4. Nosemosis Nosemosis caused by N. apis and N. ceranae cannot be evaluated only by final spore counts because Nosema spp. are obligate intracellular microsporidia with a stage-dependent infection cycle. After ingestion, mature spores germinate in the honeybee midgut and extrude a polar tube, through which the sporoplasm is transferred into epithelial cells; subsequent merogony and sporogony generate new spores and contribute to epithelial dysfunction, altered cell turnover, and spore shedding [22,23,89,90]. This biology determines which mechanisms should be considered when interpreting essential-oil studies: inhibition of spore germination or polar-tube extrusion would affect invasion, suppression of intracellular replication would reduce parasite multiplication after cell entry, and stimulation of epithelial renewal would reflect a host-mediated recovery process rather than direct parasite killing. Against this framework, thymol studies provide outcome-level anti-Nosema evidence but do not yet define the affected parasite stage. Maistrello et al. [91] reported reduced infection levels in bees fed thymol-supplemented candy, Costa et al. [92] found reduced N. ceranae development and improved longevity after thymol administration, and Glavinić et al. [93] observed lower spore loads by day 15 post-infection together with changes in oxidative-stress and immune-related parameters. These findings support biological activity, but their endpoints mainly combine parasite burden, host survival, and host physiological responses; they do not directly show whether thymol blocks polar-tube extrusion, acts on intracellular meronts or sporonts, or indirectly favors renewal of damaged midgut epithelium. The same interpretive limitation applies to other plant-derived products. Extracts from Laurus nobilis, Aster scaber, Artemisia dubia, Aristotelia chilensis, Ugni molinae, Eleutherococcus senticosus, and Andrographis paniculata have been associated with reduced spore development, lower infection intensity, or improved bee survival in experimental studies [94]. However, these endpoints remain biologically downstream unless paired with controlled spore-germination assays, polar-tube extrusion measurements, intracellular parasite quantification, and histopathological assessment of the midgut epithelium. Thus, the current plant-extract evidence broadens the candidate pool but does not yet resolve whether activity is directed at the spore, the intracellular parasite, or the host tissue response. Field evidence should be interpreted even more cautiously. Özüiçli et al. [95] evaluated thyme, peppermint, and eucalyptus essential oils under field conditions and reported the highest efficacy for thyme oil (84%), followed by peppermint (77.45%) and eucalyptus (76.10%). At colony level, these values indicate possible practical relevance, but they remain downstream outcomes that may be influenced by initial infection intensity, feeding route, season, colony demography, nutrition, gut microbiota, queen and brood status, and diagnostic timing. Future anti-Nosema studies should therefore link spore-load reduction with polar-tube extrusion, intracellular parasite burden, midgut histopathology, epithelial-renewal markers, survival, food intake, microbiota effects, and colony-level recovery before assigning a precise mode of action or recommending essential oils as field-ready nosemosis treatments. 4.5. Chalkbrood Chalkbrood, caused by A. apis, has been extensively investigated in in vitro studies. Calderone et al. [57] reported that camphor and citronellal oils at 100 µg/mL (reported as 100 ppm) inhibited fungal growth for 72 h, while cinnamon oil at the same concentration maintained inhibition for up to 168 h. Larrán et al. [96] found that coriander oil exhibited antifungal activity at concentrations of 700–900 µL/L, whereas basil and Tagetes minuta oils were effective at 800 µL/L. Additional studies have identified antifungal activity in essential oils derived from thyme, cinnamon, clove, pelargonium, Armoracia rusticana, Origanum vulgare, Cymbopogon spp., Allium sativum, Litsea cubeba, and Cinnamomum zeylanicum [97,98,99,100]. Pusceddu et al. [100] reported minimum fungicidal and sporicidal concentrations in the range of 200–400 µg/mL (reported as 200–400 ppm) for oils from Thymus herba-barona, Thymus capitatus, and Cinnamomum zeylanicum. As with other honeybee diseases, field validation remains limited. Mourad et al. [101] evaluated cedar oil and thymol following laboratory confirmation of antifungal activity and reported a 100% reduction in chalkbrood mummies with 4% cedar oil, while thymol achieved reductions ranging from 63.22% to 96.94%. These findings are particularly valuable because they link laboratory antifungal effects with colony-level outcomes. However, the evidence remains vulnerable to overinterpretation when studies rely on agar-based inhibition zones or short-term fungistatic endpoints without assessing brood-level disease recurrence, hygienic behavior, or environmental drivers. The high reduction reported in a single field context should therefore not obscure the possibility of seasonal recurrence, colony-to-colony variability, or failure under different brood-temperature and humidity conditions [101]. Chalkbrood development is strongly influenced by environmental and colony-level factors, including brood temperature, humidity, colony strength, and hygienic behavior. Therefore, antifungal activity observed under laboratory conditions should be interpreted as preliminary unless supported by robust field data. Replication across seasons and apiary contexts is particularly important because colony strength and brood microclimate can modify disease expression independently of antifungal activity. The main pathogenesis pathways relevant to interpreting disease-specific efficacy and evidence translation are summarized in Figure 1. To facilitate a structured comparison of experimental designs, control or comparator information, doses, biological outcomes, and model-level limitations, selected representative studies are reorganized by disease group and experimental scale in Table 4. To distinguish experimental promise from practical applicability, the available evidence is summarized according to the dominant experimental model, relative strength of support, and major limitations affecting reproducibility, bias, and translation to beekeeping practice (Table 5). 5. Limitations and Future Perspectives Despite the growing body of literature on essential oils, several key limitations still constrain their practical application in beekeeping. A major limitation is the chemical variability of essential oils. Their composition depends on plant species, chemotype, geographical origin, phenological stage, extraction method, and storage conditions. In the absence of detailed chemical characterization, it remains difficult to compare results across studies or to reproduce reported efficacy. Another important limitation is methodological heterogeneity. Studies differ substantially in pathogen strains, mite collection procedures, exposure routes, concentration units, incubation conditions, treatment duration, and outcome measures. This issue is particularly evident in studies on V. destructor, where contact toxicity, fumigation, direct application, and field delivery systems may yield markedly different results. The development of standardized experimental protocols is therefore essential to distinguish broadly applicable findings from laboratory-specific observations. Evidence quality is further constrained when studies use small or unspecified sample sizes, lack untreated or reference-treated controls, do not randomize colonies or cages, omit blinding of outcome assessment, or report only positive endpoints. Bee safety also remains a critical concern and should be interpreted beyond acute mortality. Essential oils are biologically active substances and may cause toxicity, repellency, feeding disruption, brood effects, queen impairment, or microbiota-mediated adverse effects when used at inappropriate doses. Accordingly, efficacy against pathogens or parasites must always be evaluated alongside organismal and microbiome-level safety at the level of adult bees, larvae, queens, brood, and entire colonies. The honeybee gut microbiota contributes to nutrient metabolism, immune maturation, and colonization resistance, and disruption of core symbionts can increase susceptibility to opportunistic pathogens [102,103]. Because ingested essential oils and propolis extracts can alter gut bacterial abundance and host physiological markers [55], broad-spectrum antimicrobial activity should be regarded as a potential safety liability as well as a therapeutic property. Unselective suppression of beneficial taxa, including Snodgrassella, Gilliamella, Lactobacillus-related clades, and Bifidobacterium, could weaken gut barrier functions, digestive resilience, and natural resistance to secondary infections or dysbiosis-associated stress. Recent risk-assessment work with an essential-oil mixture and isolated constituents found limited acute lethal toxicity under the tested laboratory conditions but compound-specific sublethal biochemical and gene-expression responses, reinforcing that safety assessment should include enzyme activity, detoxification pathways, feeding exposure, contact exposure, gut-microbiota composition, pathogen-challenge susceptibility, and chronic endpoints rather than mortality alone [104]. Formulation represents an additional challenge. High volatility and chemical instability may reduce field efficacy or result in excessive peak exposure. Advanced delivery systems, such as controlled-release formulations, microencapsulation, nanoemulsions, and optimized carriers, offer potential solutions but require thorough validation under realistic colony conditions. Recent nanoemulsion and controlled-release studies therefore support a formulation-centered research direction, but they also show that carriers, surfactants, release kinetics, repeated dosing, residue behavior, brood safety, and seasonality must be validated before nanoemulsions, microencapsulation, or other advanced delivery systems can be recommended for routine apicultural use [79,80,81,104]. A broader recent review of controlled-release essential oil formulations further supports this caution by identifying microcapsules, mesoporous silica, polymeric nanoparticles, Pickering emulsions, and metal–organic framework carriers as strategies for stabilizing volatile compounds and controlling release, while emphasizing scalability, environmental fate, and regulatory acceptance as unresolved barriers to practical deployment [105]. Within this broader safety and formulation context, exposure assessment should specify the route and duration of contact, fumigation, ingestion, and matrix-associated residues in wax, honey, pollen stores, brood food, and other hive materials. These variables determine whether a formulation produces transient worker exposure, sustained brood exposure, or colony-wide vapor exposure, and they should be reported together with chemical composition, release kinetics, dose, temperature, brood status, and colony strength [55]. Brood and queen endpoints are particularly important because adult-worker tolerance does not guarantee colony safety. In vitro larval assays showed lethal and sublethal effects of thymol in Apis mellifera larvae, demonstrating that larval exposure through contaminated food can be safety-limiting [106]. Field studies of thymol formulations further show that efficacy, persistence, residues, and colony tolerance must be evaluated together [107], and botanical-oil spray experiments reported substantial queen-loss concerns under some treatments [108]. Direct queen-specific toxicity studies remain scarce; therefore, queen mortality, egg laying, retinue behavior, supersedure, brood pattern, and worker acceptance should be mandatory endpoints before an essential-oil formulation is considered colony safe. Sublethal effects can occur without immediate mortality. Thymol exposure has been associated with concentration-dependent genotoxic effects in a honeybee cell line [109], age-dependent avoidance and fanning responses to Apiguard [110], altered olfactory memory and expression of neural target genes [111], changes in olfactory-gustatory learning congruency [112], and modified hygienic and brood-removal behavior [113]. These findings show that safety cannot be inferred from acute mortality alone, because volatile oils may affect sensory processing, disease-related social behavior, ventilation, feeding-related responses, and colony hygiene at sublethal doses. Colony organization also depends on pheromone-mediated regulation. Queen mandibular, brood, alarm, Nasonov, tergal, Dufour, and tarsal gland pheromones coordinate queen-worker interactions, retinue behavior, brood care, defense, orientation, and division of labor [114]. Because essential oils are strong volatile odorants and thymol studies show effects on olfactory memory, sensory integration, and behavior [110,111,112,113], formulations should be tested for possible interference with pheromone perception and colony communication. At present, direct colony-level evidence that essential oils disrupt honeybee pheromone systems remains limited; this should be treated as an important safety knowledge gap rather than as an established field effect. The translation of laboratory findings into beekeeping practice remains limited. Many studies demonstrate promising antimicrobial, antifungal, acaricidal, or antiparasitic activity under controlled conditions, but fewer studies assess long-term colony-level outcomes, seasonal variation, interactions with other management practices, residue risks, or performance under commercial apiary conditions. Contradictory findings should therefore be interpreted in relation to experimental scale, dose expression, formulation, delivery method, colony condition, pathogen pressure, and the biological endpoint measured rather than treated as simple confirmation or rejection of a given oil. Commercial implementation presents an additional set of limitations. Essential-oil-based products require reproducible botanical sourcing, chemical standardization, batch-to-batch quality control, stability during storage, predictable release under variable hive temperatures, acceptable residues in honey and wax, clear withdrawal or use instructions, beekeeper-safe handling, and regulatory authorization. These requirements are difficult to satisfy when active constituents are volatile, chemically variable, or effective only within a narrow dose window. Consequently, a formulation may be scientifically promising but commercially unsuitable if it cannot deliver consistent efficacy, safety, shelf life, and compliance at scale [104,105]. Future research should prioritize the use of chemically characterized oils, well-defined dose–response studies, standardized laboratory methodologies, comprehensive safety assessments, controlled field trials, and formulation development. Importantly, essential oils should be evaluated as components of integrated disease management strategies rather than as universal substitutes for established sanitary, veterinary, or acaricidal measures. To summarize the key constraints identified in the current literature and highlight priorities for future research, the main limitations and recommended directions for essential-oil-based honeybee disease control are presented in Table 6. Recent work also indicates that future studies should include microbiota-sensitive endpoints [55], together with sublethal biochemical markers and compatibility with integrated pest-management schedules, especially when essential oils are combined with established acaricides or delivered through novel formulations [82,104]. Climate-adapted field studies should also separate the effects of parasite control, nutrition, and herbal supplementation, because recent survey data suggest associations with winter survival but do not establish causal efficacy of specific plant-derived products [56]. Publication of neutral or negative findings should be encouraged, because failed field applications, dose-limiting toxicity, weak selectivity, and commercially impractical formulations are essential for defining realistic use conditions. 6. Conclusions Essential oils exhibit considerable biological potential for the control of major honeybee diseases. Their antibacterial, antifungal, acaricidal, antioxidant, colony-supportive, and virus-related properties provide a strong scientific basis for their evaluation as alternative or complementary tools in apiculture. Among these applications, the most robust practical evidence supports the use of thymol and thymol-based formulations for the control of V. destructor. For AFB, EFB, nosemosis, and chalkbrood, numerous essential oils demonstrate promising in vitro activity; however, evidence from well-controlled field studies remains limited. Critical gaps persist in relation to chemical standardization, dose optimization, formulation strategies, delivery systems, and comprehensive evaluation of bee and brood safety. At the same time, the evidence does not support a uniformly positive assessment: several oils show weak, inconsistent, or non-transferable performance once tested beyond controlled laboratory conditions. Practical suitability therefore depends on colony-level safety evidence that includes reproductive, developmental, behavioral, microbiota-related, and communication-mediated endpoints. The practical effectiveness of essential oils depends not only on their intrinsic biological activity but also on multiple interacting factors, including chemical composition, concentration, formulation, method of application, and colony-level conditions. Therefore, essential oils should not be regarded as universal substitutes for conventional disease-control measures. Instead, they should be considered promising components of integrated honeybee health management strategies. The most recent evidence strengthens this conclusion by showing that updated formulations can improve exposure and mite reduction, but also that field efficacy and colony strength remain decisive criteria for translation into practice [79,80,81,82]. A realistic assessment should therefore treat essential oils as candidates requiring rigorous product-level validation, not as ready substitutes for established sanitary, nutritional, and veterinary measures.